# Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma

> **NCT05889949** · — · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 200 (estimated)

## Conditions studied

- Radiomics
- Hepatocellular Carcinoma (HCC)
- Transcatheter Arterial Chemoembolization (TACE)
- Microvascular Invasion (MVI)
- Multi-kinase Inhibitors (MKI)

## Interventions

- **DRUG:** Sorafenib
- **DRUG:** Lenvatinib

## Key facts

- **NCT ID:** NCT05889949
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2023-05-31
- **Final completion:** 2023-05-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05889949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05889949, "Microvascular Invasion for Guiding Treatment of Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05889949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*